Oliver Venn
Oliver Venn
Staff Scientist, GRAIL
Verified email at grailbio.com
Title
Cited by
Cited by
Year
System and method for participation in energy-related markets
J Crabtree, A McCord, J Jia, O Venn, M Hoak, A Charneski, P Crabtree
US Patent App. 12/802,705, 2010
4262010
A fine-scale chimpanzee genetic map from population sequencing
A Auton, A Fledel-Alon, S Pfeifer, O Venn, L Ségurel, T Street, EM Leffler, ...
science 336 (6078), 193-198, 2012
2492012
A fine-scale chimpanzee genetic map from population sequencing
A Auton, A Fledel-Alon, S Pfeifer, O Venn, L Ségurel, T Street, EM Leffler, ...
science 336 (6078), 193-198, 2012
2492012
Arabidopsis meiotic crossover hot spots overlap with H2A.Z nucleosomes at gene promoters
K Choi, X Zhao, KA Kelly, O Venn, JD Higgins, NE Yelina, TJ Hardcastle, ...
Nature genetics 45 (11), 1327, 2013
2312013
Multiple instances of ancient balancing selection shared between humans and chimpanzees
EM Leffler, Z Gao, S Pfeifer, L Ségurel, A Auton, O Venn, R Bowden, ...
Science 339 (6127), 1578-1582, 2013
2302013
System and method for trading complex energy securities
J Crabtree, P Rajan, BR Galvin, A McCord, O Venn
US Patent App. 12/799,310, 2010
2042010
System and method for single-action energy resource scheduling and participation in energy-related securities
J Crubtree, P Rajan, BR Galvin, A McCord, O Venn
US Patent App. 12/584,332, 2010
1892010
Stable recombination hotspots in birds
S Singhal, EM Leffler, K Sannareddy, I Turner, O Venn, DM Hooper, ...
Science 350 (6263), 928-932, 2015
1812015
Strong male bias drives germline mutation in chimpanzees
O Venn, I Turner, I Mathieson, N de Groot, R Bontrop, G McVean
Science 344 (6189), 1272-1275, 2014
1162014
Development of a comprehensive cell-free DNA (cfDNA) assay for early detection of multiple tumor types: The Circulating Cell-free Genome Atlas (CCGA) study.
EA Klein, E Hubbell, T Maddala, A Aravanis, JF Beausang, D Filippova, ...
Journal of Clinical Oncology 36 (15_suppl), 12021-12021, 2018
312018
Genome-wide sequencing for early stage lung cancer detection from plasma cell-free DNA (cfDNA): The Circulating Cancer Genome Atlas (CCGA) study.
GR Oxnard, T Maddala, E Hubbell, A Aravanis, N Zhang, O Venn, ...
Journal of Clinical Oncology 36 (18_suppl), LBA8501-LBA8501, 2018
212018
Breast cancer cell-free DNA (cfDNA) profiles reflect underlying tumor biology: The Circulating Cell-Free Genome Atlas (CCGA) study.
MC Liu, T Maddala, A Aravanis, E Hubbell, JF Beausang, D Filippova, ...
Journal of Clinical Oncology 36 (15_suppl), 536-536, 2018
162018
Prevalence of clonal hematopoiesis of indeterminate potential (CHIP) measured by an ultra-sensitive sequencing assay: Exploratory analysis of the Circulating Cancer Genome …
C Swanton, O Venn, A Aravanis, E Hubbell, T Maddala, JF Beausang, ...
Journal of Clinical Oncology 36 (15_suppl), 12003-12003, 2018
162018
Cell-free DNA (cfDNA) mutations from clonal hematopoiesis: Implications for interpretation of liquid biopsy tests.
P Razavi, BT Li, C Hou, R Shen, O Venn, RS Lim, E Hubbell, I De Bruijn, ...
Journal of Clinical Oncology 35 (15_suppl), 11526-11526, 2017
162017
50O Plasma cell-free DNA (cfDNA) assays for early multi-cancer detection: The circulating cell-free genome atlas (CCGA) study
MC Liu, E Klein, E Hubbell, T Maddala, AM Aravanis, JF Beausang, ...
Annals of Oncology 29 (suppl_8), mdy269. 048, 2018
52018
Characterisation of the changing genomic landscape of metastatic melanoma using cell free DNA
A Cutts, O Venn, A Dilthey, A Gupta, D Vavoulis, H Dreau, M Middleton, ...
NPJ genomic medicine 2 (1), 25, 2017
32017
Abstract LB-343: Development of plasma cell-free DNA (cfDNA) assays for early cancer detection: first insights from the Circulating Cell-Free Genome Atlas Study (CCGA)
AA Aravanis, GR Oxnard, T Maddala, E Hubbell, O Venn, A Jamshidi, ...
Cancer Research 78 (13 Supplement), LB-343-LB-343, 2018
2018
Inferring the fine-scale structure and evolution of recombination from high-throughput genome sequencing
OC Venn
University of Oxford, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–18